Anti-elF2 alpha (phospho S52) 抗体 - N-terminal
Anti-elF2 alpha (phospho S52) antibody - N-terminal
Be the first to review this product! Submit a review
|
(7 Publications)
Rabbit Polyclonal EIF2S1 phospho S52 antibody. N-terminal. Suitable for WB and reacts with Rat, Human samples. Cited in 7 publications. Immunogen corresponding to Synthetic Peptide within Human EIF2S1 phospho S52.
別名を表示する
EIF2A, EIF2S1, Eukaryotic translation initiation factor 2 subunit 1, Eukaryotic translation initiation factor 2 subunit alpha, eIF-2-alpha, eIF-2A, eIF-2alpha, eIF2-alpha
- WB
Supplier Data
Western blot - Anti-elF2 alpha (phospho S52) antibody - N-terminal (AB227593)
10% SDS-PAGE gel.
All lanes:
Western blot - Anti-elF2 alpha (phospho S52) antibody - N-terminal (ab227593) at 1/500 dilution
Lane 1:
HEK-293T (human epithelial cell line from embryonic kidney transformed with large T antigen) whole cell extract at 30 µg
Lane 2:
HEK-293T (human epithelial cell line from embryonic kidney transformed with large T antigen) treated with 25 µg/ml anisomycin for 16 hours, whole cell extract at 30 µg
Predicted band size: 36 kDa
false
- WB
Supplier Data
Western blot - Anti-elF2 alpha (phospho S52) antibody - N-terminal (AB227593)
10% SDS-PAGE gel.
All lanes:
Western blot - Anti-elF2 alpha (phospho S52) antibody - N-terminal (ab227593) at 1/500 dilution
Lane 1:
HepG2 (human liver hepatocellular carcinoma cell line) whole cell extract at 30 µg
Lane 2:
HepG2 (human liver hepatocellular carcinoma cell line) treated with 3 µM thapsigargin for 12 hours, whole cell extract at 30 µg
Predicted band size: 36 kDa
false
- WB
Supplier Data
Western blot - Anti-elF2 alpha (phospho S52) antibody - N-terminal (AB227593)
10% SDS-PAGE gel.
All lanes:
Western blot - Anti-elF2 alpha (phospho S52) antibody - N-terminal (ab227593) at 1/500 dilution
Lane 1:
HeLa (human epithelial cell line from cervix adenocarcinoma) whole cell extract at 30 µg
Lane 2:
HeLa (human epithelial cell line from cervix adenocarcinoma) treated with 4 µg/ml tunicamycin for 16 hours, whole cell extract at 30 µg
Predicted band size: 36 kDa
false
- WB
Supplier Data
Western blot - Anti-elF2 alpha (phospho S52) antibody - N-terminal (AB227593)
10% SDS-PAGE gel.
All lanes:
Western blot - Anti-elF2 alpha (phospho S52) antibody - N-terminal (ab227593) at 1/1000 dilution
Lane 1:
PC-12 (rat adrenal gland pheochromocytoma cell line) whole cell extract at 30 µg
Lane 2:
PC-12 (rat adrenal gland pheochromocytoma cell line) treated with 300 µM thapsigargin for 8 hours, whole cell extract at 30 µg
Predicted band size: 36 kDa
false
Reactivity data
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
EIF2 alpha modulates protein synthesis in response to cellular stress signals. When phosphorylated eIF2 alpha inhibits the formation of the active eIF2-GTP-Met-tRNA complex reducing general protein translation and facilitating expression of stress-response genes. As part of the eIF2 complex it interacts with other proteins like eIF2β and eIF2γ highlighting its role in translation regulation and cellular response to various stimuli. This control mechanism is important for cellular adaptation to changing environmental conditions.
Pathways
EIF2 alpha plays an important role in the integrated stress response (ISR) and the unfolded protein response (UPR). Phosphorylation of eIF2 alpha by kinases such as PERK and PKR links it to these pathways and demonstrates its key position in cellular stress response networks. eIF2 alpha's activity regulates downstream factors including activating transcription factor 4 (ATF4) which mediates the expression of genes involved in the stress response. This interconnectivity with key signaling pathways highlights its regulatory importance.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (7)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 15:8586 PubMed39362879
2024
Applications
Unspecified application
Species
Unspecified reactive species
In vivo (Athens, Greece) 38:2228-2238 PubMed39187325
2024
Applications
Unspecified application
Species
Unspecified reactive species
Asian journal of andrology 25:152-157 PubMed36629160
2023
Applications
Unspecified application
Species
Unspecified reactive species
Reproductive biology and endocrinology : RB&E 19:135 PubMed34496874
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 12:314 PubMed33762577
2021
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of pharmacology and experimental therapeutics 377:146-156 PubMed33509902
2021
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 17:7886-7892 PubMed29620275
2018
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com